Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13205142 | 0.79 | MGAM (0.43) | — | |
| SCHEMBL13205140 | 0.78 | GRIK1 (0.36) | PTGS1GRIK1GRIK2 | |
| SCHEMBL13205139 | 0.76 | HCAR2 (0.36) | — | |
| SCHEMBL17075354 | 0.75 | PRKCA (0.37) | PTGS1NR1I2PGRADORA3PTGS2 | |
| SCHEMBL17075355 | 0.75 | PRKCA (0.37) | PTGS1NR1I2PGRADORA3PTGS2 | |
| SCHEMBL8961878 | 0.70 | PTGS1 (0.40) | PTGS1NR1I2PGRADORA3PTGS2 | |
| SCHEMBL24829887 | 0.69 | ALDH1A1 (0.44) | PTGS1GRIK1GRIK2NR1I2ADORA3 | |
| SCHEMBL5933141 | 0.68 | — | — | |
| SCHEMBL11723677 | 0.68 | ALDH1A1 (0.47) | PTGS1NR1I2PGRADORA3PTGS2 | |
| SCHEMBL11723671 | 0.68 | ALDH1A1 (0.47) | PTGS1NR1I2PGRADORA3PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7781391-B2 | Amine/amide-functionalized lipophiles | CRODA, INC. (US) | 2010-08-24 | — | — | US | disclosed |
| US-20070238896-A1 | Amine/amide-functionalized lipophiles | CRODA, INC. (US) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238896-A1 | Amine/amide-functionalized lipophiles | TYR, LPO, CUTA | PTGS1 4202/4885GRIK1 3977/4885GRIK2 4204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.